Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Clonidine generic and brand name?Trospium chloride us approval date?Generic for briviact?Evaluate the digital health company form health on finasteride?Adapalene products market?
See the DrugPatentWatch profile for Entresto
Entresto (sacubitril/valsartan) is used to treat certain adults with chronic heart failure, specifically to help reduce the risk of cardiovascular death and hospitalization in people with reduced or mildly reduced ejection fraction.
It is used for: - Chronic heart failure with reduced ejection fraction (HFrEF) - Chronic heart failure with mildly reduced ejection fraction (HFmrEF), in appropriate patients
Entresto combines two medicines: - Sacubitril: helps increase natriuretic peptides (by inhibiting neprilysin), which supports salt/water balance and beneficial cardiovascular signaling - Valsartan: blocks the angiotensin II receptor (ARBs), lowering harmful vasoconstriction and strain on the heart
In most searches, that phrase is shorthand for “what is Entresto used for?”—i.e., what condition it’s prescribed to manage (heart failure) and what patient group it’s intended for (HFrEF/HFmrEF).
Other Questions About Entresto :